NA Foot and Ankle Allograft Market - Industry Trends and Forecast to 2029
- Published Date: 2022-12-24
- Report ID: 143387
- Pages: 225
-
Format:
Short Description
North America foot and ankle allografts Market, By Product Type (Allograft Wedges, Allograft Tendons, Allograft Acellular Dermal Matrix, Cartilage Allograft Matrix, Skin Allografts, Amniotic Membranes), Surgery Type (Orthopedic Reconstruction, Cartilage Restoration, Soft Tissue Tendon & Ligament Repair, Wound Care) Procedure (Midfoot Procedures, Hindfoot Procedures), End User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, Academic and Research Institutes, Other End Users) Industry Trends & Forecast to 2029.
Market Definition:
An allograft of tissue obtained from a donor of the same species as, but with a different genetic make-up from, the recipient, as a tissue transplant between two humans.
The demand for foot and ankle allografts has been increased with the increasing number of market players for the allografts usage in North America. The foot and ankle allografts market is growing due to introduction of technological and innovative products, increasing healthcare expenditure and rising disposable income. The market will grow in forecasted period due to exploration of emerging markets, strategic initiatives by market players.
Market Segmentation:
North America foot and ankle allografts market is categorized into four notable segment which product type, surgery type, procedure and end user.
On the basis of product type, North America foot and ankle allograft market is segmented into allograft wedges, allograft tendons, allograft, acellular dermal matrix, cartilage allograft matrix, skin allografts, and amniotic membranes. In 2022, allograft wedges segment in North America foot and ankle allograft market is expected to growing in the market with the increasing advancement in the technology.
On the basis of surgery type, North America foot and ankle allograft market is segmented into orthopedic reconstruction, cartilage restoration, soft tissue tendon & ligament repair and wound care. In 2022, orthopedic reconstruction segment in North America foot and ankle allograft market is expected to growing in the market with the increasing number of orthopedic surgeries.
On the basis of procedure, North America foot and ankle allograft market is segmented into midfoot procedures and hind-foot procedures. In 2022, midfoot procedures segment in North America foot and ankle allograft market is expected to grow with the increasing use of foot and ankle allograft and increasing number of geriatric population.
On the basis of end user, North America foot and ankle allograft market is segmented into hospitals, orthopedic clinics, ambulatory surgical centers, academic and research institutes and other end users. In 2022, hospital segment in North America foot and ankle allograft market is expected to growing in the market with the increasing patient population in hospitals
Market Players
The key market players for North America foot and ankle allografts market are listed below:
CONMED Corporation.
Stryker,
Bioventus,
AlloSource,
Smith Nephew,
Arthrex, Inc.,
Organogenesis Inc.,
PARAGON 28, INC,
Amniox Medical, Inc.,
ALON SOURCE GROUP,
TABLE OF CONTENTS
1 INTRODUCTION 31
1.1 OBJECTIVES OF THE STUDY 31
1.2 MARKET DEFINITION 31
1.3 OVERVIEW OF NORTH AMERICA FOOT AND ANKLE ALLOGRAFTS MARKET 31
1.4 LIMITATIONS 33
1.5 MARKETS COVERED 33
2 MARKET SEGMENTATION 36
2.1 MARKETS COVERED 36
2.2 GEOGRAPHICAL SCOPE 37
2.3 YEARS CONSIDERED FOR THE STUDY 38
2.4 CURRENCY AND PRICING 38
2.5 DBMR TRIPOD DATA VALIDATION MODEL 39
2.6 MULTIVARIATE MODELLING 42
2.7 END USER LIFELINE CURVE 42
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 43
2.9 DBMR MARKET POSITION GRID 44
2.10 MARKET APPLICATION COVERAGE GRID 45
2.11 VENDOR SHARE ANALYSIS 46
2.12 SECONDARY SOURCES 47
2.13 ASSUMPTIONS 47
3 EXECUTIVE SUMMARY 48
4 PREMIUM INSIGHTS 50
4.1 PORTERS FIVE FORCES 51
5 INDUSTRIAL INSIGHTS: 52
5.1 CONCLUSION: 52
6 NORTH AMERICA FOOT AND ANKLE ALLOGRAFTS MARKET: REGULATIONS 53
6.1 U.S. 54
6.2 CANADA 55
6.3 EUROPE 55
7 MARKET OVERVIEW 57
7.1 DRIVERS 59
7.1.1 GROWING GERIATRIC POPULATION 59
7.1.2 INCREASE IN PREVALENCE OF MUSCULOSKELETAL DISORDER 59
7.1.3 INCREASE IN HEALTHCARE EXPENDITURE 60
7.1.4 INCREASE IN STRATEGIC INITIATIVES BY MAJOR MARKET PLAYERS 61
7.2 RESTRAINTS 62
7.2.1 STRINGENT REGULATORY 62
7.2.2 COMPLICATION AND RISK OF ALLOGRAFTS 62
7.3 OPPORTUNITIES 63
7.3.1 INCREASE IN NUMBER OF SPORTS INJURIES 63
7.3.2 RISE IN AWARENESS INITIATIVES ABOUT THE ALLOGRAFT PROCEDURE: 64
7.3.3 INCREASING RISK OF OSTEOPOROSIS AND OSTEOARTHRITIS: 65
7.4 CHALLENGES 66
7.4.1 COVID-19 IMPACT ON NORTH AMERICA FOOT AND ANKLE ALLOGRAFTS MARKET 66
7.4.2 ALLOGRAFT IS OFTEN CONSIDERED TOO EXPENSIVE IN LOW-INCOME TO MIDDLE-INCOME COUNTRIES: 67
7.4.3 HIGHER ADOPTION OF ALTERNATIVE THERAPIES FOR THE TREATMENT OF FOOT AND ANKLE DISORDERS: 68
8 NORTH AMERICA FOOT AND ANKLE ALLOGRAFTS MARKET, BY PRODUCT TYPE 69
8.1 OVERVIEW 70
8.2 ALLOGRAFT WEDGES 73
8.3 ALLOGRAFT TENDONS 73
8.4 ALLOGRAFT ACELLULAR DERMAL MATRIX 74
8.5 CARTILAGE ALLOGRAFT MATRIX 75
8.6 SKIN ALLOGRAFTS 76
8.7 AMNIOTIC MEMBRANES 77
9 NORTH AMERICA FOOT AND ANKLE ALLOGRAFTS MARKET, BY SURGERY TYPE 78
9.1 OVERVIEW 79
9.2 ORTHOPEDIC RECONSTRUCTION 82
9.2.1 NON-UNIONS FRACTURES 83
9.2.2 ARTHRODESIS PROCEDURES 83
9.2.3 OSTEOTOMY PROCEDURES 83
9.3 CARTILAGE RESTORATION 83
9.3.1 TALAR DOME REPAIR 84
9.3.2 TIBIAL PLAFOND REPAIR 84
9.3.3 METATARSAL REPAIR 84
9.3.4 TALONAVICULAR JOINT REPAIR 84
9.3.5 SUBTALAR JOINT REPAIR 84
9.4 SOFT TISSUE TENDON & LIGAMENT REPAIR 84
9.4.1 TENDON AUGMENTATION 85
9.4.2 LIGAMENT REPAIR 85
9.4.3 FAT PAD REPLACEMENT 85
9.4.4 PLANTAR PLATE REPAIR 86
9.5 WOUND CARE 86
9.5.1 ANKLE ULCER TREATMENT 87
9.5.2 NEUROPATHIC FOOT ULCER TREATMENT 87
10 NORTH AMERICA FOOT AND ANKLE ALLOGRAFTS MARKET, BY PROCEDURE 88
10.1 OVERVIEW 89
10.2 MIDFOOT PROCEDURES 92
10.2.1 CUBOID FRACTURE 93
10.2.2 FIRST TARSOMETATARSAL JOINT ARTHRODESIS 93
10.2.3 MEDIAL COLUMN ARTHRODESIS 93
10.2.4 LISFRANC 93
10.2.5 MEDIAL CUNEIFORM DORSAL OPENING WEDGE (COTTON) OSTEOTOMY 93
10.2.6 NAVICULAR CUNEIFORM ARTHRODESIS 93
10.2.7 NAVICULAR FRACTURE 93
10.2.8 OTHER MIDFOOT PROCEDURES 93
10.3 HIND-FOOT PROCEDURES 93
10.3.1 CALCANEAL FRACTURE 94
10.3.2 LATERAL COLUMN LENGTHENING 94
10.3.3 TALONAVICULAR JOINT ARTHRODESIS 95
10.3.4 TRIPLE ARTHRODESIS 95
10.3.5 OTHER HINDFOOT PROCEDURES 95
11 NORTH AMERICA FOOT AND ANKLE ALLOGRAFTS MARKET, BY END USER 96
11.1 OVERVIEW 97
11.2 HOSPITALS 100
11.3 ORTHOPEDIC CLINICS 100
11.4 AMBULATORY SURGICAL CENTERS 101
11.5 ACADEMIC AND RESEARCH INSTITUTES 102
11.6 OTHER END USERS 103
12 NORTH AMERICA FOOT AND ANKLE ALLOGRAFT MARKET, BY REGION 104
12.1 NORTH AMERICA 105
12.1.1 U.S. 113
12.1.2 CANADA 116
12.1.3 MEXICO 119
13 NORTH AMERICA FOOT AND ANKLE ALLOGRAFTS MARKET: COMPANY LANDSCAPE 122
13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 122
14 SWOT ANALYSIS 123
15 COMPANY PROFILE 124
15.1 LIFENET HEALTH 124
15.1.1 COMPANY SNAPSHOT 124
15.1.2 COMPANY SHARE ANALYSIS 124
15.1.3 PRODUCT PORTFOLIO 125
15.1.4 RECENT DEVELOPMENTS 126
15.1.4.1 CONFERENCE 126
15.1.4.2 PRODUCT LAUNCH 127
15.2 ZIMMER BIOMET 128
15.2.1 COMPANY SNAPSHOT 128
15.2.2 REVENUE ANALYSIS 128
15.2.3 COMPANY SHARE ANALYSIS 129
15.2.4 PRODUCT PORTFOLIO 129
15.2.5 RECENT DEVELOPMENT 129
15.2.5.1 PARTNERSHIP 129
15.3 JOHNSON & JOHNSON SERVICES, INC. 130
15.3.1 COMPANY SNAPSHOT 130
15.3.2 REVENUE ANALYSIS 130
15.3.3 COMPANY SHARE ANALYSIS 131
15.3.4 PRODUCT PORTFOLIO 131
15.3.5 RECENT DEVELOPMENTS 131
15.3.5.1 EVENT 131
15.3.5.2 PRODUCT LAUNCH 131
15.4 INTEGRA LIFESCIENCES 132
15.4.1 COMPANY SNAPSHOT 132
15.4.2 REVENUE ANALYSIS 132
15.4.3 COMPANY SHARE ANALYSIS 133
15.4.4 PRODUCT PORTFOLIO 133
15.4.5 RECENT DEVELOPMENTS 133
15.4.5.1 POSITIVE CLINICAL OUTCOME 133
15.4.5.2 AGREEMENT 133
15.4.5.3 ACQUISITION 134
15.5 CONMED CORPORATION (2022) 135
15.5.1 COMPANY SNAPSHOT 135
15.5.2 REVENUE ANALYSIS 135
15.5.3 COMPANY SHARE ANALYSIS 136
15.5.4 PRODUCT PORTFOLIO 136
15.5.5 RECENT DEVELOPMENT 137
15.5.5.1 ACQUISITION 137
15.6 ALLOSOURCE 138
15.6.1 COMPANY SNAPSHOT 138
15.6.2 PRODUCT PORTFOLIO 138
15.6.3 RECENT DEVELOPMENT 139
15.6.3.1 PRODUCT LAUNCH 139
15.7 ALON SOURCE GROUP 140
15.7.1 COMPANY SNAPSHOT 140
15.7.2 PRODUCT PORTFOLIO 140
15.7.3 RECENT DEVELOPMENT 140
15.8 AMNIOX MEDICAL INC. 141
15.8.1 COMPANY SNAPSHOT 141
15.8.2 PRODUCT PORTFOLIO 141
15.8.3 RECENT DEVELOPMENT 141
15.8.3.1 PARTNERSHIP 141
15.9 ARTHREX 142
15.9.1 COMPANY SNAPSHOT 142
15.9.2 PRODUCT PORTFOLIO 142
15.9.3 RECENT DEVELOPMENT 142
15.9.3.1 PRODUCT LAUNCH 142
15.10 BIOVENTUS 143
15.10.1 COMPANY SNAPSHOT 143
15.10.2 REVENUE ANALYSIS 143
15.10.3 PRODUCT PORTFOLIO 144
15.10.4 RECENT DEVELOPMENT 144
15.10.4.1 CO-DEVELOPMENT 144
15.11 BONE BANK ALLOGRAFTS 145
15.11.1 COMPANY SNAPSHOT 145
15.11.2 PRODUCT PORTFOLIO 145
15.11.3 RECENT DEVELOPMENTS 145
15.11.3.1 PARTNERSHIP 145
15.12 GLOBUS MEDICAL 146
15.12.1 COMPANY SNAPSHOT 146
15.12.2 REVENUE ANALYSIS 146
15.12.3 PRODUCT PORTFOLIO 147
15.12.4 RECENT DEVELOPMENTS 147
15.12.4.1 M&A 147
15.13 INSTITUT STRAUMANN 148
15.13.1 COMPANY SNAPSHOT 148
15.13.2 REVENUE ANALYSIS 148
15.13.3 PRODUCT PORTFOLIO 149
15.13.4 RECENT DEVELOPMENT 149
15.14 JRF ORTHO 150
15.14.1 COMPANY SNAPSHOT 150
15.14.2 PRODUCT PORTFOLIO 150
15.14.3 RECENT DEVELOPMENT 151
15.14.3.1 PARTNERSHIP 151
15.15 NVISION BIOMEDICAL TECHNOLOGIES. 152
15.15.1 COMPANY SNAPSHOT 152
15.15.2 PRODUCT PORTFOLIO 152
15.15.3 RECENT DEVELOPMENT 152
15.15.3.1 ACQUISITION 152
15.16 PARAGON28, INC. 153
15.16.1 COMPANY SNAPSHOT 153
15.16.2 REVENUE ANALYSIS 153
15.16.3 PRODUCT PORTFOLIO 154
15.16.4 RECENT DEVELOPMENT 154
15.16.4.1 ACQUISITION 154
15.17 ORGANOGENESIS INC 155
15.17.1 COMPANY SNAPSHOT 155
15.17.2 REVENUE ANALYSIS 155
15.17.3 PRODUCT PORTFOLIO 156
15.17.4 RECENT DEVELOPMENTS 156
15.17.4.1 CONFERENCE 156
15.17.4.2 ACQUISITION 156
15.18 SMITH + NEPHEW 157
15.18.1 COMPANY SNAPSHOT 157
15.18.2 REVENUE ANALYSIS 157
15.18.3 PRODUCT PORTFOLIO 158
15.18.4 RECENT DEVELOPMENTS 158
15.18.4.1 EVENT 158
15.18.4.2 ACQUISITION 158
15.19 STRYKER 159
15.19.1 COMPANY SNAPSHOT 159
15.19.2 REVENUE ANALYSIS 159
15.19.3 PRODUCT PORTFOLIO 160
15.19.4 RECENT DEVELOPMENT 160
16 QUESTIONNAIRE 161
17 RELATED REPORTS 164
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
